Position in ABVX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,233,124
+$926,514 QoQ
Shares Held
20,055
+107.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cinctive Capital Management LP holds $200,361,017 across 44 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
350,165 | $46,477,400 | |
| 2 | INSM |
INSMED Inc
|
161,996 | $17,272,013 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,712 | $13,268,651 | |
| 4 | CYTK |
Cytokinetics Inc
|
137,838 | $11,742,419 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
226,140 | $8,003,094 | |
| 6 | NTHI |
Neonc Technologies Holdings, Inc.
|
1,607,464 | $7,281,811 | |
| 7 | ERAS |
Erasca, Inc.
|
391,642 | $7,174,881 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
16,367 | $6,083,122 |
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,233,124 | 20,055 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,306,610 | 9,689 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||